MAP Pharma - WACC Analysis

MAP Pharma (Weighted Average Cost of Capital (WACC) Analysis)

placeholder_large_analysis.png

Banner%20-%20The%20perfect%20tool%20for%20investors%281%29.gif

Helpful Information for MAP Pharma's Analysis

What is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine MAP Pharma's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for MAP Pharma. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in MAP Pharma before they make value investing decisions. This WACC analysis is used in MAP Pharma's discounted cash flow (DCF) valuation and see how the WACC calculation affect's MAP Pharma's company valuation.

WACC Analysis Information

1. The WACC (discount rate) calculation for MAP Pharma uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for MAP Pharma over the long term. If there are any short-term differences between the industry WACC and MAP Pharma's WACC (discount rate), then MAP Pharma is more likely to revert to the industry WACC (discount rate) over the long term.

2. The WACC calculation uses the higher of MAP Pharma's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and MAP Pharma uses a significant proportion of equity capital.